Skip to main content
AXSM logo

Axsome Therapeutics, Inc.

AXSMNASDAQHealthcareBiotechnology

$157.14Today:- (-)1Y +26.46%

As of Oct 16, 2026 close

Market cap
$8.38B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$123.42$260.19
Volume (live)
-
Avg. volume (3M)
787.52K

Axsome Therapeutics, Inc. (AXSM) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Axsome Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 19 professional research analysts

Consensus Rating

Buy
Based on 19 unique analysts
(23 total ratings in last 90 days)
High Confidence15.0:1 Buy/Sell

Average Price Target

$287.87
+83.19% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest AXSM Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Jason Gerberry
BofA Securities
BuyMaintains
$276.00
Ahan Chakraborty
Zacks Equity Research
HoldInitiates Coverage
-
Leonid Timashev
RBC Capital
BuyMaintains
$297.00 → $295.00
Matthew Hershenhorn
Oppenheimer
BuyMaintains
$280.00
Benjamin Burnett
Wells Fargo
BuyMaintains
$256.00
David Hoang
Deutsche Bank
BuyMaintains
$280.00 → $267.00
Ram Selvaraju
HC Wainwright
BuyReiterates
$290.00
Sean Laaman
Morgan Stanley
HoldMaintains
$247.00
Srikripa Devarakonda
Truist
BuyInitiates
$200.00 → $285.00
David Amsellem
Piper Sandler
BuyReiterates
$258.00
Leonid Timashev
RBC Capital
BuyMaintains
$297.00
Malcolm Hoffman
BMO Capital
BuyReiterates
$310.00
Graig Suvannavejh
Mizuho
BuyMaintains
$316.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Edmund Ingham
Forbes
SellInitiates Coverage
-
Andrew Tsai
Jefferies
BuyMaintains
$380.00
Yatin Suneja
Guggenheim
BuyMaintains
$260.00 → $275.00
Myles Minter
William Blair
BuyMaintains
-
Joseph Thome
TD Cowen
BuyMaintains
$300.00 → $315.00
Jason Gerberry
BofA Securities
BuyReiterates
$276.00
Malcolm Hoffman
BMO Capital
BuyMaintains
$310.00
Ami Fadia
Needham
BuyReiterates
$267.00 → $268.00
Sean Laaman
Morgan Stanley
HoldMaintains
$242.00 → $251.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for AXSM?

The analyst consensus rating for AXSM is Buy, based on the latest ratings from 19 analysts over the last 90 days.

What is the average price target for AXSM?

The average 12-month price target for AXSM is $287.87, representing an upside of 83.2% from the Oct 16, 2026 close of $157.14.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.